Postpartum peripheral nerve issues are an unusual obstetrical complication, with most instances ensuing from intrinsic obstetric palsies. We current the case of a full-term nulliparous pregnant 33-year-old girl with a vacuum-assisted vaginal supply as a result of a protracted second stage of labour and occipitoposterior place of the fetal head. For analgesia, a mixed spinal-epidural approach was used. 4 hours after supply, the affected person skilled a painless uneven motor deficit and hypoesthesia within the decrease limbs, adopted by sphincter disturbance. Emergent MRI was unremarkable. Electromyography confirmed indicators of a bilateral lumbosacral radiculopathy. The affected person skilled a gradual restoration over the next 2 months.
Though a definitive aetiological prognosis couldn’t be confirmed, a lumbosacral polyradiculopathy as a result of intrinsic obstetric complication was thought of. The affected person offered a number of danger components identified to be related to intrinsic obstetric palsies. Obstetricians and anaesthesiologists have an necessary function in stopping and diagnosing postpartum peripheral nerve disorderswe current a case of CIDP with hypertrophic nerves and evaluate it to earlier studies. The principle scientific findings had been insidious onset, gait ataxia and sensory signs. Electrodiagnostic research confirmed very sluggish nerve conduction velocities, a number of conduction blocks, distal CMAP length improve and absence of F-waves.
The protein degree within the cerebrospinal fluid was very excessive. Nerve ultrasound confirmed swelling of all peripheral nerves outdoors entrapment websites, with vital variability inside totally different segments of the identical nerve; nerves had been massively enlarged (as much as 10-fold regular values). Mind MRI confirmed hypertrophic cranial nerves, with gadolinium-enhancement. Spinal MRI confirmed hypertrophy of spinal roots and cauda equine, with gadolinium enhancement. Genetic take a look at (PMP22 duplication/deletion, Complete Exome Sequencing panel for neuropathies) resulted detrimental.
The affected person had a relapsing-remitting course and responded to immunoglobulin remedy. Spinal twine compression secondary to nerve root hypertrophy is commonly attributed to hereditary neuropathies. Nevertheless, to keep away from misdiagnosis, uncommon immune-mediated neuropathy reminiscent of persistent inflammatory demyelinating polyradiculoneuropathy (CIDP) shouldn’t be neglected. This report presents a case of multilevel nerve root hypertrophy resulting in vital twine compression from CIDP. Within the current report, the authors display {that a} myxopapillary ependymoma might current as an remoted gluteal mass hooked up to the coccygeal nerve, with out frank CNS involvement.
Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats
Neuronal aggregates of misfolded alpha-synuclein protein are discovered within the mind and periphery of sufferers with Parkinson’s illness. Braak and colleagues have hypothesized that the preliminary formation of misfolded alpha-synuclein might begin within the intestine, after which unfold to the mind by way of peripheral autonomic nerves hereby affecting a number of organs, together with the guts and gut. Age is taken into account the best danger issue for Parkinson’s illness, however the impact of age on the formation of pathology and its propagation has not been studied intimately.
We aimed to research whether or not propagation of alpha-synuclein pathology from the intestine to the mind is extra environment friendly in outdated versus younger wild-type rats, upon gastrointestinal injection of aggregated alpha-synuclein. Our outcomes display a sturdy age-dependent gut-to-brain and brain-to-gut unfold of alpha-synuclein pathology alongside the sympathetic and parasympathetic nerves, leading to age-dependent dysfunction of the guts and abdomen, as noticed in sufferers with Parkinson’s illness.
Furthermore, alpha-synuclein pathology is extra densely packed and immune to enzymatic digestion in outdated rats, indicating an age-dependent maturation of alpha-synuclein aggregates. Our research is the primary to supply an in depth investigation of alpha-synuclein pathology in a number of organs inside one animal mannequin, together with the mind, pores and skin, coronary heart, gut, spinal twine and autonomic ganglia. Taken collectively, our findings counsel that age is an important issue for alpha-synuclein aggregation and full propagation to coronary heart, abdomen and pores and skin, much like sufferers.
On condition that age is the best danger issue for human Parkinson’s illness, it appears probably that older experimental animals will yield probably the most related and dependable findings. These outcomes have necessary implications for future analysis to optimize diagnostics and therapeutics in Parkinson’s illness and different age-associated synucleinopathies. Elevated emphasis ought to be positioned on utilizing aged animals in preclinical research and to elucidate the character of age-dependent interactions. Moreover, an interdisciplinary method to surgical resection of this lesion seems to symbolize an efficient remedy modality.
Surgical administration of a uncommon myxopapillary ependymoma of the gluteal area: A case report
Ependymomas are uncommon tumors originating from neuroepithelial cells lining the wall of the ventricles or central canal of the spinal twine. Whereas these tumors primarily happen inside the central nervous system (CNS), there are occasional studies in kids and younger grownup sufferers with a main tumor incidence outdoors of the CNS. Ependymomas of the sacrococcygeal area have been occasionally described within the literature with no normal of care established. We current a case report and evaluate of the literature concerning this uncommon entity.
 Antibody) Nerve Growth Factor (NGF) Antibody |
|
20-abx173738 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx173739 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx177728 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx177729 |
Abbexa |
-
EUR 477.60
-
EUR 159.60
-
EUR 1279.20
-
EUR 627.60
-
EUR 360.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx177730 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx177731 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx177732 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx177733 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx177734 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx177735 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx214597 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx214598 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
abx033672-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
|
Nerve Growth Factor (NGF) Antibody |
|
abx033672-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx131371 |
Abbexa |
-
EUR 477.60
-
EUR 159.60
-
EUR 1296.00
-
EUR 644.40
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx323432 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx328869 |
Abbexa |
|
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx319461 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx000643 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
|
Nerve Growth Factor (NGF) Antibody |
|
20-abx301783 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
) beta nerve growth factor Antibody (HRP) |
|
20-abx108937 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
) beta nerve growth factor Antibody (FITC) |
|
20-abx107518 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
) beta nerve growth factor Antibody (Biotin) |
|
20-abx106104 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody (HRP)) Nerve Growth Factor (NGF) Antibody (HRP) |
|
20-abx314512 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Nerve Growth Factor (NGF) Antibody (HRP) |
|
20-abx319462 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody (FITC)) Nerve Growth Factor (NGF) Antibody (FITC) |
|
20-abx314513 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody) beta Nerve Growth Factor (Ngf) Antibody |
|
20-abx110383 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody) Nerve Growth Factor IB (NGFIB) Antibody |
|
20-abx173740 |
Abbexa |
|
|
|
|
Nerve Growth Factor IB (NGFIB) Antibody |
|
20-abx177736 |
Abbexa |
-
EUR 543.60
-
EUR 159.60
-
EUR 1562.40
-
EUR 744.00
-
EUR 410.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Antibody Pair) Nerve Growth Factor (NGF) Antibody Pair |
|
20-abx370100 |
Abbexa |
|
- 10 × 96 tests
- 5 × 96 tests
|
|
|
Nerve Growth Factor (NGF) Antibody Pair |
|
20-abx370140 |
Abbexa |
|
- 10 × 96 tests
- 5 × 96 tests
|
|
|
Nerve Growth Factor (NGF) Antibody (FITC) |
|
20-abx319463 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 NGF Antibody / Beta Nerve Growth Factor |
|
F54948-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
|
Description: NGFB is a member of the NGF-beta family. It is a secreted protein which homodimerizes and is incorporated into a larger complex. This protein has nerve growth stimulating activity and the complex is involved in the regulation of growth and the differentiation of sympathetic and certain sensory neurons. Mutations in the gene encoding NGFB have been associated with hereditary sensory and autonomic neuropathy, type 5 (HSAN5), and dysregulation of the gene's expression is associated with allergic rhinitis. |
NGF Antibody / Beta Nerve Growth Factor |
|
F54948-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
|
Description: NGFB is a member of the NGF-beta family. It is a secreted protein which homodimerizes and is incorporated into a larger complex. This protein has nerve growth stimulating activity and the complex is involved in the regulation of growth and the differentiation of sympathetic and certain sensory neurons. Mutations in the gene encoding NGFB have been associated with hereditary sensory and autonomic neuropathy, type 5 (HSAN5), and dysregulation of the gene's expression is associated with allergic rhinitis. |
NGF Antibody / Beta Nerve Growth Factor |
|
R32657 |
NSJ Bioreagents |
100ug |
EUR 356.15 |
|
Description: Nerve growth factor is a polypeptide involved in the regulation of growth and differentiation of sympathetic and certain sensory neurons. The nucleotide sequence of human and mouse beta-NGF are very similar. The beta-subunits of nerve growth factor (NGFB) have been assigned to mouse chromosome 3 and human chromosome 1p22. The human gene for the beta subunit of nerve growth factor is located on the proximal short arm of chromosome 1. A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception. |
NGF Antibody / Beta Nerve Growth Factor |
|
RQ6782 |
NSJ Bioreagents |
100ug |
EUR 356.15 |
|
Description: Nerve growth factor (NGF) is a neurotrophic factor and neuropeptide primarily involved in the regulation of growth, maintenance, proliferation, and survival of certain target neurons. It is mapped to 1p13.2. This gene is a member of the NGF-beta family and encodes a secreted protein which homodimerizes and is incorporated into a larger complex. This protein has nerve growth stimulating activity and the complex is involved in the regulation of growth and the differentiation of sympathetic and certain sensory neurons. Mutations in this gene have been associated with hereditary sensory and autonomic neuropathy, type 5 (HSAN5), and dysregulation of this gene's expression is associated with allergic rhinitis. |
NGF Antibody / Beta Nerve Growth Factor |
|
RQ4871 |
NSJ Bioreagents |
100ul |
EUR 356.15 |
|
Description: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems. [UniProt] |
 Neutralizing Antibody) Anti-NGF (Nerve Growth Factor) Neutralizing Antibody |
|
100436-1 |
BPS Bioscience |
50 µg |
EUR 355 |
|
Description: Anti-NGF Neutralizing Recombinant Human antibody. This_x000D_ antibody has not been tested for crossreactivity_x000D_ with other species. |
Anti-NGF (Nerve Growth Factor) Neutralizing Antibody |
|
100436-2 |
BPS Bioscience |
100 µg |
EUR 490 |
|
Description: Anti-NGF Neutralizing Recombinant Human antibody. This_x000D_ antibody has not been tested for crossreactivity_x000D_ with other species. |
 Antibody (Biotin)) Nerve Growth Factor (NGF) Antibody (Biotin) |
|
20-abx314514 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Nerve Growth Factor (NGF) Antibody (Biotin) |
|
20-abx271922 |
Abbexa |
-
EUR 477.60
-
EUR 276.00
-
EUR 1296.00
-
EUR 644.40
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Nerve Growth Factor (NGF) Antibody (Biotin) |
|
20-abx319464 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody) Nerve Growth Factor Receptor (NGFR) Antibody |
|
20-abx318150 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
20-abx241119 |
Abbexa |
|
|
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
20-abx214766 |
Abbexa |
|
|
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
abx332306-100ul |
Abbexa |
100 ul |
EUR 510 |
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
20-abx327262 |
Abbexa |
|
|
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
20-abx114049 |
Abbexa |
|
|
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
abx037622-100ug |
Abbexa |
100 ug |
EUR 469.2 |
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
20-abx126983 |
Abbexa |
|
|
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
20-abx125372 |
Abbexa |
-
EUR 594.00
-
EUR 844.80
-
EUR 427.20
|
|
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
20-abx126252 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
20-abx328143 |
Abbexa |
|
|
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
abx433034-200ul |
Abbexa |
200 ul |
EUR 460.8 |
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
20-abx001709 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
abx011244-100ul |
Abbexa |
100 ul |
EUR 493.2 |
|
|
Nerve Growth Factor Receptor (NGFR) Antibody |
|
P1020-01m |
SAB |
0.1m |
EUR 312 |
Nerve Growth Factor Receptor (NGFR) Antibody |
|
P1020-1ml |
SAB |
1ml |
EUR 1198.8 |
 Antibody (HRP)) Nerve Growth Factor Receptor (NGFR) Antibody (HRP) |
|
20-abx316117 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody) VGF Nerve Growth Factor Inducible (VGF) Antibody |
|
20-abx242538 |
Abbexa |
|
|
|
|
VGF Nerve Growth Factor Inducible (VGF) Antibody |
|
20-abx103386 |
Abbexa |
-
EUR 493.20
-
EUR 159.60
-
EUR 1378.80
-
EUR 678.00
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
VGF Nerve Growth Factor Inducible (VGF) Antibody |
|
20-abx175093 |
Abbexa |
|
|
|
|
VGF Nerve Growth Factor Inducible (VGF) Antibody |
|
20-abx178875 |
Abbexa |
|
|
|
|
VGF Nerve Growth Factor Inducible (VGF) Antibody |
|
20-abx178876 |
Abbexa |
|
|
|
|
VGF Nerve Growth Factor Inducible (VGF) Antibody |
|
20-abx178877 |
Abbexa |
|
|
|
|
VGF Nerve Growth Factor Inducible (VGF) Antibody |
|
20-abx214163 |
Abbexa |
|
|
|
|
VGF Nerve Growth Factor Inducible (VGF) Antibody |
|
abx332494-100ul |
Abbexa |
100 ul |
EUR 510 |
|
|
VGF Nerve Growth Factor Inducible (VGF) Antibody |
|
20-abx327688 |
Abbexa |
|
|
|
|
VGF Nerve Growth Factor Inducible (VGF) Antibody |
|
20-abx132002 |
Abbexa |
-
EUR 393.60
-
EUR 978.00
-
EUR 510.00
-
EUR 184.80
-
EUR 309.60
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
VGF Nerve Growth Factor Inducible (VGF) Antibody |
|
20-abx328805 |
Abbexa |
|
|
|
|
 Antibody (FITC)) Nerve Growth Factor Receptor (NGFR) Antibody (FITC) |
|
20-abx316118 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
(NGFR5) Antibody) NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC800890-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF680 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC800890-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF680 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC810890-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF680R conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC810890-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF680R conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC940890-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF594 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC940890-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF594 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC700890-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF770 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC700890-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF770 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC880890-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF488A conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC880890-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF488A conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC050890-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF405M conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC050890-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF405M conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC040890-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF405S conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC040890-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF405S conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC400890-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF640R conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC400890-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF640R conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNCB0890-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), Biotin conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNCB0890-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), Biotin conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNCAP0890-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNCAP0890-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNCA0890-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), APC conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNCR0890-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), RPE conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNCP0890-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), PerCP conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNUM0890-50 |
Biotium |
50uL |
EUR 474 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), 1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNCH0890-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNCH0890-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNUB0890-100 |
Biotium |
100uL |
EUR 250.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), Concentration: 0.2mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNUB0890-500 |
Biotium |
500uL |
EUR 549.6 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), Concentration: 0.2mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC610890-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF660R conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC610890-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF660R conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC550890-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF555 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC550890-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF555 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC430890-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF543 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC430890-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF543 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC680890-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF568 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC680890-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF568 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC470890-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF647 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NGFR5) Antibody |
|
BNC470890-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NGFR5), CF647 conjugate, Concentration: 0.1mg/mL |
 Antibody (Biotin)) Nerve Growth Factor Receptor (NGFR) Antibody (Biotin) |
|
20-abx316119 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Monoclonal Antibody (Human)) Nerve Growth Factor (NGF) Monoclonal Antibody (Human) |
|
4-MAA105Hu21 |
Cloud-Clone |
-
EUR 273.60
-
EUR 2662.80
-
EUR 670.80
-
EUR 339.60
-
EUR 247.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Human Nerve Growth Factor (NGF) |
 Polyclonal Antibody (Human)) Nerve Growth Factor (NGF) Polyclonal Antibody (Human) |
|
4-PAA105Hu01 |
Cloud-Clone |
-
EUR 260.40
-
EUR 2457.60
-
EUR 624.00
-
EUR 321.60
-
EUR 241.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Nerve Growth Factor (NGF) |
Nerve Growth Factor (NGF) Polyclonal Antibody (Human) |
|
4-PAA105Hu06 |
Cloud-Clone |
-
EUR 274.80
-
EUR 2678.40
-
EUR 674.40
-
EUR 340.80
-
EUR 247.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Nerve Growth Factor (NGF) |
(NTR/912) Antibody) NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC800912-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF680 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC800912-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF680 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC810912-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF680R conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC810912-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF680R conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC940912-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF594 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC940912-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF594 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC700912-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF770 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC700912-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF770 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC880912-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF488A conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC880912-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF488A conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC050912-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF405M conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC050912-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF405M conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC040912-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF405S conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC040912-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF405S conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC400912-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF640R conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC400912-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF640R conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNCAP0912-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNCAP0912-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNCA0912-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), APC conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNCB0912-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), Biotin conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNCB0912-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), Biotin conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNCR0912-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), RPE conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNCP0912-250 |
Biotium |
250uL |
EUR 459.6 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), PerCP conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNUM0912-50 |
Biotium |
50uL |
EUR 474 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), 1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNCH0912-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNCH0912-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNUB0912-100 |
Biotium |
100uL |
EUR 250.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), Concentration: 0.2mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNUB0912-500 |
Biotium |
500uL |
EUR 549.6 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), Concentration: 0.2mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC610912-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF660R conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC610912-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF660R conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC550912-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF555 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC550912-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF555 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC430912-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF543 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC430912-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF543 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC680912-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF568 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC680912-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF568 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC470912-100 |
Biotium |
100uL |
EUR 238.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF647 conjugate, Concentration: 0.1mg/mL |
NGFR (Nerve Growth Factor Receptor)(NTR/912) Antibody |
|
BNC470912-500 |
Biotium |
500uL |
EUR 652.8 |
|
Description: Primary antibody against NGFR (Nerve Growth Factor Receptor)(NTR/912), CF647 conjugate, Concentration: 0.1mg/mL |
 Monoclonal Antibody (Human), PE) Nerve Growth Factor (NGF) Monoclonal Antibody (Human), PE |
|
4-MAA105Hu21-PE |
Cloud-Clone |
-
EUR 328.80
-
EUR 2787.60
-
EUR 804.00
-
EUR 408.00
-
EUR 223.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Mouse monoclonal antibody against Human Nerve Growth Factor (NGF). This antibody is labeled with PE. |
A 24-year-old girl offered with proper gluteal ache worsened by sitting and a palpable delicate tissue mass of the sacrococcygeal area. Magnetic resonance imaging revealed a 3.7 cm cystic mass centered in the correct gluteal area. She underwent a biopsy at an out of doors establishment, with histology revealing myxopapillary ependymoma. The affected person was referred to our hospital and underwent an interdisciplinary neurosurgical and orthopedic oncology en bloc resection of the ependymoma, which intraoperatively appeared to originate from the coccygeal nerve.
